Johnson & Johnson (JNJ) Tax Provisions (2009 - 2026)
Johnson & Johnson recorded quarterly Tax Provisions of $755.0 million in Q1 2026, up 603.33% quarter-over-quarter from -$150.0 million in Q4 2025, and down 71.31% year-over-year from $2.6 billion in Q1 2025.
Johnson & Johnson's Tax Provisions history runs 18 years deep, the most recent figure standing at $755.0 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 71.31% year-over-year to $755.0 million; the TTM figure through Mar 2026 stood at $3.9 billion (down 18.65% YoY), while the FY2025 annual figure was $5.8 billion, up 120.41% from the prior year.
- Tax Provisions came in at $755.0 million for Q1 2026 at Johnson & Johnson, up from -$150.0 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $2.6 billion in Q1 2025 to a low of -$796.0 million in Q2 2023.
- A 5-year average of $863.6 million and a median of $862.0 million in 2022 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions slumped 211.64% in 2023 and soared 473.42% in 2025, its largest moves.
- Johnson & Johnson's Tax Provisions stood at $862.0 million in 2022, then dropped by 19.49% to $694.0 million in 2023, then sank by 34.29% to $456.0 million in 2024, then plunged by 132.89% to -$150.0 million in 2025, then jumped by 603.33% to $755.0 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $755.0 million, -$150.0 million, and $2.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 1.45 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 755.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 342.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 709.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 265.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 559.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 461.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 561.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 755.00 Mn |
| Dec 28, 2025 | -150.00 Mn |
| Sep 28, 2025 | 2.34 Bn |
| Jun 29, 2025 | 954.00 Mn |
| Mar 30, 2025 | 2.63 Bn |
| Dec 29, 2024 | 456.00 Mn |
| Sep 29, 2024 | 644.00 Mn |
| Jun 30, 2024 | 1.06 Bn |
| Mar 31, 2024 | 459.00 Mn |
| Dec 31, 2023 | 694.00 Mn |
| Oct 1, 2023 | 908.00 Mn |
| Jul 2, 2023 | 930.00 Mn |
| Apr 2, 2023 | -796.00 Mn |
| Jan 1, 2023 | 1.19 Bn |
| Oct 2, 2022 | 862.00 Mn |
| Jul 3, 2022 | 1.03 Bn |
| Apr 3, 2022 | 713.00 Mn |
| Oct 3, 2021 | 182.00 Mn |
| Jul 4, 2021 | 384.00 Mn |
| Apr 4, 2021 | 1.23 Bn |
| Jan 3, 2021 | -91.00 Mn |
| Sep 27, 2020 | 847.00 Mn |
| Jun 28, 2020 | 314.00 Mn |
| Mar 29, 2020 | 713.00 Mn |
| Dec 29, 2019 | 208.00 Mn |
| Sep 29, 2019 | -106.00 Mn |
| Jun 30, 2019 | 1.43 Bn |
| Mar 31, 2019 | 673.00 Mn |
| Dec 30, 2018 | 80.00 Mn |
| Sep 30, 2018 | 489.00 Mn |
| Jul 1, 2018 | 1.02 Bn |
| Apr 1, 2018 | 1.11 Bn |
| Dec 31, 2017 | 13.27 Bn |
| Oct 1, 2017 | 1.03 Bn |
| Jul 2, 2017 | 921.00 Mn |
| Apr 2, 2017 | 1.15 Bn |
| Jan 1, 2017 | 19.00 Mn |
| Oct 2, 2016 | 1.01 Bn |
| Jul 3, 2016 | 907.00 Mn |
| Apr 3, 2016 | 837.00 Mn |
| Sep 27, 2015 | 764.00 Mn |
| Jun 28, 2015 | 1.23 Bn |
| Mar 29, 2015 | 1.26 Bn |
| Dec 28, 2014 | 182.00 Mn |
| Sep 28, 2014 | 2.06 Bn |
| Jun 29, 2014 | 1.30 Bn |
| Mar 30, 2014 | 697.00 Mn |
| Dec 29, 2013 | -769.00 Mn |
| Sep 29, 2013 | 685.00 Mn |
| Jun 30, 2013 | 960.00 Mn |
| Mar 31, 2013 | 764.00 Mn |
| Dec 30, 2012 | 533.00 Mn |
| Sep 30, 2012 | 966.00 Mn |
| Jul 1, 2012 | 627.00 Mn |
| Apr 1, 2012 | 1.14 Bn |
| Jan 1, 2012 | -638.00 Mn |
| Oct 2, 2011 | 909.00 Mn |
| Jul 3, 2011 | 646.00 Mn |
| Apr 3, 2011 | 1.03 Bn |
| Oct 3, 2010 | 802.00 Mn |
| Jul 4, 2010 | 771.00 Mn |
| Apr 4, 2010 | 1.75 Bn |
| Jan 3, 2010 | 398.00 Mn |
| Sep 27, 2009 | 900.00 Mn |
| Jun 28, 2009 | 1.06 Bn |
| Mar 29, 2009 | 1.14 Bn |